COMMUNIQUÉS West-GlobeNewswire

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

04/01/2018 - 22:01

MALVERN, Pa., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]

Aduro Biotech to Present at the 36th Annual J.P. Morgan Healthcare Conference

04/01/2018 - 22:01

BERKELEY, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the 36 th Annual [...]

AveXis Announces Alignment with FDA on Next Steps Toward a BLA Submission for AVXS-101 in SMA Type 1

04/01/2018 - 22:00

– Company to submit information requested by FDA to the IND on an on-going basis – – AveXis plans to request a pre-BLA meeting in Q2 2018 – – Conference call and webcast today at 4:30 pm EST – CHICAGO, Jan. 04, 2018 ( [...]

Nohla Therapeutics Announces Hiring of Jim Johnson as Chief Financial Officer

04/01/2018 - 22:00

SEATTLE, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading cell therapy company that provides a short-term bridge to long-term health for patients with critical diseases, today announced the [...]

Stop e-Prescribing Bill, Says President of the Association of American Physicians and Surgeons

04/01/2018 - 20:08

TUCSON, Ariz., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Forcing doctors to electronically prescribe all controlled drugs, as in Oklahoma proposed bill Req. No. 8141 , is a “flawed and misguided” idea that will not reduce [...]

Accelerate Diagnostics to Present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco

04/01/2018 - 19:44

TUCSON, Ariz., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer is scheduled to speak at the 36th Annual J.P. Morgan Healthcare [...]

Tauriga Sciences Inc. Completes Purchase of its First Tranche of Crypto Currency Groestlcoin

04/01/2018 - 17:55

NEW YORK, NY, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]

Eloxx Pharmaceuticals Chairman and CEO Robert Ward to Participate in a Panel Discussion at the Biotech Showcase 2018 Conference

04/01/2018 - 17:39

WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (OTC:SVOND), a clinical-stage biopharmaceutical company developing novel small molecule medicines to treat rare and ultra-rare [...]

LHC Group to Present at 36th Annual J.P. Morgan Healthcare Conference

04/01/2018 - 17:15

LAFAYETTE, La., Jan. 04, 2018 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG ) announced today that Keith G. Myers, chief executive officer of LHC Group, will present at the 36 th Annual J.P. Morgan Healthcare [...]

Tempus and Vanderbilt-Ingram Cancer Center Announce Data Initiative to Improve Outcomes for Cancer Patients

04/01/2018 - 17:00

CHICAGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and Vanderbilt-Ingram [...]

NeuroMetrix CEO to Participate in CES 2018 Panel on Opioid Crisis

04/01/2018 - 17:00

WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will participate in a panel at the Digital [...]

WishBone Medical, Inc. Names Andrew J. Miclot as President

04/01/2018 - 16:19

WARSAW, Ind., Jan. 04, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a new global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants in sterile packed, single-use [...]

INC Research/inVentiv Health Becomes Syneos Health™

04/01/2018 - 15:28

RALEIGH, N.C., Jan. 04, 2018 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq: INCR ) today announced it has changed its brand identity to Syneos Health, Inc., effective January 4, 2018. More than 21,000 of the [...]

CASMED Reports Preliminary Net Sales for the 2017 Fourth Quarter

04/01/2018 - 15:21

BRANFORD, Conn., Jan. 04, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in non-invasive cerebral oximetry patient monitoring, reports preliminary unaudited topline results for the [...]

Ultragenyx Announces Update to UX007 Development Program in Long-Chain Fatty Acid Oxidation Disorder Patients

04/01/2018 - 15:08

NOVATO, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]

Sienna Biopharmaceuticals to Present at J.P. Morgan Healthcare Conference

04/01/2018 - 15:05

WESTLAKE VILLAGE, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of [...]

Houston Dermatologist Reveals Laser Treatment Options for Birthmarks

04/01/2018 - 15:01

HOUSTON, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Most birthmarks, including Becker’s Nevus and Nevus of Ota , do not pose a threat to one’s health, explains Houston dermatologist Paul M. Friedman, MD. However, he says that [...]

Adverum Biotechnologies Provides 2018 Outlook

04/01/2018 - 15:00

MENLO PARK, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]

Rexahn Pharmaceuticals Announces the Appointment of Douglas J. Swirsky as President and Chief Financial Officer

04/01/2018 - 15:00

ROCKVILLE, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today [...]